Skip to main content

Official Journal of the Italian Society of Orthopaedics and Traumatology

Table 2 Generalities and patient demographics of the included studies

From: Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: a meta-analysis

Author, year, ref. Follow-up (months) Type of treatment Type of protocol Samples (n) Mean age (years) Female gender (%)
Barthel et al. 2002 [17] 12 Meloxicam 7.5 mg daily / 14 days 24 65 42%
Meloxicam 15 mg daily / 14 days 115 63 65%
Indomethacin 100 mg daily / 14 days 111 63 64%
Grohs et al. 2007 [7] 12 Rofecoxib 25 mg daily / 7 days 50 60 66%
Indomethacin 100 mg per daily / 7 days 50 60 60%
Legenstein et al. 2003 [34] 6 Indomethacin 150 mg daily / 12 days 58 68 59%
Meloxicam 7.5 mg daily / 12 days 58 65 74%
Romano et al. 1992 [35] 24 Indomethacin 100 mg per daily / 20 days 229 62 72%
Celecoxib 400 mg daily / 20 days 147 59 74%
Saudan et al. 2007 [25] 3 Celecoxib 400 mg daily / 10 days 117 69 53%
Ibuprofen 1200 mg daily / 10 days 123 70 54%
Van der Heide et al. 2004 [9] 6 Indomethacin 150 mg daily / 7 days 89 67 68%
Meloxicam 15 mg daily / 7 days 92 67 68%
Van der Heide et al. 2007 [36] 12 Indomethacin 150 mg daily / 7 days 89   62%
Rofecoxib 50 mg daily / 7 days 85   62%
Winkler et al. 2016 [4] 6 Diclofenac 150 mg daily / 9 days 44 61 45%
Etoricoxib 90 mg daily / 9 days 45 60 46%